137 related articles for article (PubMed ID: 31525647)
1. Willingness to pay for a Rift valley fever (RVF) vaccine among Kenyan cattle producers.
Wanyoike F; Mtimet N; Bett B
Prev Vet Med; 2019 Nov; 171():104763. PubMed ID: 31525647
[TBL] [Abstract][Full Text] [Related]
2. Farmers' willingness to pay for foot and mouth disease vaccine in different cattle production systems in Amhara region of Ethiopia.
Jemberu WT; Molla W; Dagnew T; Rushton J; Hogeveen H
PLoS One; 2020; 15(10):e0239829. PubMed ID: 33006982
[TBL] [Abstract][Full Text] [Related]
3. Farmers' preference and willingness to pay for a multivalent lumpy skin disease and Rift Valley fever novel vaccine: A discrete choice experiment in the Free State province, South Africa.
Masemola M; Owusu-Sekyere E; Ogundeji AA; van Niekerk HN; Chaminuka P
Prev Vet Med; 2021 Apr; 189():105293. PubMed ID: 33631510
[TBL] [Abstract][Full Text] [Related]
4. Willingness to pay for contagious bovine pleuropneumonia vaccination in Narok South District of Kenya.
Kairu-Wanyoike SW; Kaitibie S; Heffernan C; Taylor NM; Gitau GK; Kiara H; McKeever D
Prev Vet Med; 2014 Aug; 115(3-4):130-42. PubMed ID: 24774477
[TBL] [Abstract][Full Text] [Related]
5. Farmers' valuation and willingness to pay for vaccines to protect livestock resources against priority infectious diseases in Ghana.
Nuvey FS; Hanley N; Simpson K; Haydon DT; Hattendorf J; Mensah GI; Addo KK; Bonfoh B; Zinsstag J; Fink G
Prev Vet Med; 2023 Oct; 219():106028. PubMed ID: 37774497
[TBL] [Abstract][Full Text] [Related]
6. Rift Valley fever knowledge, mitigation strategies and communication preferences among male and female livestock farmers in Eastern Province, Rwanda.
Smith LJ; Schurer JM; Ntakiyisumba E; Shyaka A; Amuguni JH
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009705. PubMed ID: 34424895
[TBL] [Abstract][Full Text] [Related]
7. Modelling Vaccination Strategies against Rift Valley Fever in Livestock in Kenya.
Gachohi JM; Njenga MK; Kitala P; Bett B
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005049. PubMed ID: 27973528
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination.
Wilson WC; Bawa B; Drolet BS; Lehiy C; Faburay B; Jasperson DC; Reister L; Gaudreault NN; Carlson J; Ma W; Morozov I; McVey DS; Richt JA
Vet Microbiol; 2014 Aug; 172(1-2):44-50. PubMed ID: 24856133
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
von Teichman B; Engelbrecht A; Zulu G; Dungu B; Pardini A; Bouloy M
Vaccine; 2011 Aug; 29(34):5771-7. PubMed ID: 21664400
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
[TBL] [Abstract][Full Text] [Related]
11. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of rift valley fever in cattle in Ijara district, Kenya.
Owange NO; Ogara WO; Affognon H; Peter GB; Kasiiti J; Okuthe S; Onyango-Ouma W; Landmann T; Sang R; Mbabu M
Prev Vet Med; 2014 Nov; 117(1):121-8. PubMed ID: 25217406
[TBL] [Abstract][Full Text] [Related]
13. The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO/FAO meeting.
Bull World Health Organ; 1983; 61(2):261-8. PubMed ID: 6602663
[TBL] [Abstract][Full Text] [Related]
14. Indigenous knowledge of Rift Valley Fever among Somali nomadic pastoralists and its implications on public health delivery approaches in Ijara sub-County, North Eastern Kenya.
Muga GO; Onyango-Ouma W; Sang R; Affognon H
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009166. PubMed ID: 33617555
[TBL] [Abstract][Full Text] [Related]
15. Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique.
Lagerqvist N; Moiane B; Bucht G; Fafetine J; Paweska JT; Lundkvist A; Falk KI
Vaccine; 2012 Oct; 30(46):6534-40. PubMed ID: 22947138
[TBL] [Abstract][Full Text] [Related]
16. An inactivated rift valley fever vaccine.
Barnard BJ; Botha MJ
J S Afr Vet Assoc; 1977 Mar; 48(1):45-8. PubMed ID: 874947
[TBL] [Abstract][Full Text] [Related]
17. Dynamic risk model for Rift Valley fever outbreaks in Kenya based on climate and disease outbreak data.
Gikungu D; Wakhungu J; Siamba D; Neyole E; Muita R; Bett B
Geospat Health; 2016 May; 11(2):377. PubMed ID: 27245792
[TBL] [Abstract][Full Text] [Related]
18. Knowledge, Attitudes and Practices (KAP) on Rift Valley Fever among Pastoralist Communities of Ijara District, North Eastern Kenya.
Abdi IH; Affognon HD; Wanjoya AK; Onyango-Ouma W; Sang R
PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004239. PubMed ID: 26566218
[TBL] [Abstract][Full Text] [Related]
19. Willingness to Vaccinate (WTV) and Willingness to Pay (WTP) for Vaccination Against Peste des Petits Ruminants (PPR) in Mali.
Wane A; Dione M; Wieland B; Rich KM; Yena AS; Fall A
Front Vet Sci; 2019; 6():488. PubMed ID: 32010711
[TBL] [Abstract][Full Text] [Related]
20. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
Ikegami T
Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
